Article
Genomic landscape of drug binding and pharmacogenetic variation across diverse populations using SNPdrug3D.
Nature communications - 9 Jun 2026
Malik Ashar J, Kenanov Dimitar, Chong Cheng-Shoong, Ozturk Mert Burak, Wang Qiqi, Chang Hong-Yun, Hebrard Maxime, Ho Ying Swan, Wang Zhenxun, Limviphuvadh Vachiranee, Miyajima Jhoann M T, Kannan Srinivasaraghavan, Magallanes Roberto Tirado, Sim Xueling, Chai Jin Fang, Davila Sonia, Yeo Khung Keong, Leong Khai Pang, Goh Liuh Ling, Karnani Neerja, Eriksson Johan Gunnar, Cheng Ching-Yu, Wong Tien Yin, Loh Marie, Dalan Rinkoo, Khor Chiea Chuen, Chew Guo-Liang, Lim Weng Khong, Ngeow Joanne, Chambers John C, Tai E Shyong, Bertin Nicolas, Tan Chris Soon Heng, Koh Judice, Tan Patrick, Verma Chandra S, Maurer-Stroh Sebastian
Abstract excerpt
One of the promises of precision medicine is to understand and act on inter-individual genetic differences in drug responses. SNPdrug3D contains the complete genomic landscape of missense single nucleotide variants (SNV) across the human proteome and at a population-wide level that could affect drug binding. Here, we map SNVs in over 80,000 individuals from the Singapore SG10K Health and gnomAD cohorts to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
